The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Scapa Healthcare, Industrial Heads Resign

Mon, 04th May 2020 15:42

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Scapa Group PLC - healthcare and industrial design - Hires John Petreanu as president of Healthcare, replacing Joe Doherty, from Monday. Petreanu most recently was vice president of operations for Viant Medical, a service provider to medical device makers, having previously been chief operating officer for Scapa Healthcare. Meanwhile, Scapa Chief Executive Heejae Chae will take on the additional role of president of Industrial, replacing Sevan Demirdogen. Both Doherty and Demirdogen resign "to pursue other business opportunities". Additionally, Chae volunteers for a 20% cut in basic salary during the Covid-19 crisis. Scapa expects to report underlying trading profit for the financial year that ended March 31 in line with the guidance it provided back in February.

----------

Attraqt Group PLC - online retail software - Hires Mark Adams as CEO, joining on June 22 from BigCommerce, an e-commerce platform provider. Current CEO Luke McKeever will move to non-executive director at that time and Nick Habgood will move back to non-executive chair from interim executive chair. Attraqt was named a BigCommerce Technology Partner back in February, and the two companies have a number of joint customers and pipeline prospects.

----------

Red Rock Resources PLC - gold, manganese and mineral development - Scott Kaintz moves from chief operating officer and chief financial officer to non-executive director, effective from Friday last week, due to becoming chief executive officer of Regency Mines PLC. Red Rock said Kaintz will remain in the non-executive role to provide a transition once a new CFO is found.

----------

Clipper Logistics PLC - e-fulfilment and returns management - Promotes COO Stefan Van-Hoof to deputy CEO, reporting to CEO Tony Mannix, effective immediately. Van-Hoof joined Clipper in 2016 and previously was managing director of its European business. Martin O'Grady is promoted to COO to replace Van-Hoof from senior operations director.

----------

Target Healthcare REIT PLC - investor in care homes - Alison Fyfe hired as independent non-executive director, effective from Friday last week. Fyfe worked for Royal Bank of Scotland Group PLC for 19 years, ending as head of real estate restructuring in Scotland in 2015.

----------

Motif Bio PLC - AIM cash shell - Graham Lumsden steps down as CEO to become non-executive director, while CFO Jonathan Gold adds the role of president & chief business officer. Bruce Williams remains chair, and Chris Wardhaugh is added as non-executive director. Wardhaugh is chief business officer of MGB Biopharma Ltd and is founder of Sercader Ltd, a life sciences advisory firm. Williams said Wardhaugh's transactional experience will be useful as Motif Bio looks for a reverse takeover candidate, which it must do by July 28 or have its shares suspended from trading on AIM. The company said it has GBP230,000, giving it a cash runway into June.

----------

Big Yellow Group PLC - storage space provider - Hires Laela Tabrizi as non-executive director from July 1. Tabrizi is CFO of MotorK, which provides digital solutions for automotive sales and marketing. Georgina Harvey to step down as non-executive director after seven years at upcoming annual general meeting, normally held in July. Last month Big Yellow raised GBP81.9 million in a share placing.

----------

Trident Resources PLC - mining royalty and streaming - Hires Al Gourley as non-executive director. Gourley is the London managing partner of law firm Fasken Martineau and has been director of several Toronto and London listed mining and mineral exploration companies.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Jul 2015 06:40

Motif Bio's Iclaprim Eligible For Incentives With New US Designation

Read more
23 Jun 2015 11:20

Motif Bio raises £22m via share placing

Biopharmaceutical company Motif Bio has raised £22m via a conditional share placing with institutional investors. The London-listed group said "the placing is conditional on securing shareholder approval and on a successful qualified infection disease product designation being given to its iclaprim

Read more
23 Jun 2015 09:28

Amphion Innovations Confident After Motif IPO, 2014 Asset Value Fall

Read more
23 Jun 2015 06:58

Motif Bio Raises GBP22 Million In Discounted Share Placing (ALLISS)

Read more
9 Jun 2015 08:27

Motif Bio Annual Loss Widened Slightly Ahead Of London IPO

Read more
1 Jun 2015 11:15

Motif Bio signs deal with leading clinical research organisation

A wholly-owned subsidiary of antibiotic developer Motif Bio has signed letters of intent and interim agreements with a leading global clinical research organisation (CRO). Motif has agreed to invest more than $0.95m under the agreements, which must be paid by the end of July. Under the agreements,

Read more
1 Jun 2015 07:23

Motif Bio Shares Up As It Moves Towards Iclaprim Clinical Trials

Read more
28 May 2015 09:47

Motif Bio Gets FDA Minutes Confirming Phase III Plans For Iclaprim

Read more
7 May 2015 09:12

Motif Bio Exploring Funding Options For Iclaprim Trials (ALLISS)

Read more
15 Apr 2015 07:31

LONDON MORNING BRIEFING: Next And Burberry Shares In Fashion

Read more
15 Apr 2015 07:10

Amphion Shares Up As Motif Bio Gets US FDA Approval For Iclaprim Trial

Read more
2 Apr 2015 11:46

Motif Bio makes AIM debut, seeks approval for Iclaprim treatment

Clinical stage biopharmaceutical group Motif Bio began trading on AIM on Thursday, after raising £2.8m in its initial public offering. The group, whose 44.09% of issued equity is owned by Amphion, placed shares at 20p each, said it had 64,238,442 ordinary shares in issue and a market capitalisation

Read more
2 Apr 2015 08:19

BCA Marketplace, Marshall Motor And Motif Bio Begin Trading (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.